Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system

J Hum Hypertens. 2005 Aug;19(8):659-61. doi: 10.1038/sj.jhh.1001879.

Authors

E N Libhaber, G R Norton, C D Libhaber, G P Candy, A J Woodiwiss, K Sliwa, M R Essop, P Sareli

PMID: 15905887
DOI: 10.1038/sj.jhh.1001879

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Angiotensin II Type 1 Receptor Blockers / administration & dosage
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Black People*
Blood Pressure / physiology*
Cardiomegaly / complications
Cardiomegaly / drug therapy*
Cardiomegaly / physiopathology*
Diuretics / administration & dosage
Drug Therapy, Combination
Female
Humans
Hypertension / complications
Hypertension / drug therapy
Hypertension / physiopathology
Male
Middle Aged
Prospective Studies
Remission Induction

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Diuretics